Skip to main content
SpringerLink
Log in

In Vivo Models for the Evaluation of Antithrombotics and Thrombolytics

  • Protocol
  • First Online:
Anticoagulants, Antiplatelets, and Thrombolytics

Part of the book series: Methods in Molecular Biology ((MIMB,volume 663))

Abstract

The development and application of animal models of thrombosis have played a crucial role in the discovery and validation of novel drug targets and the selection of new agents for clinical evaluation, and have informed dosing and safety information for clinical trials. These models also provide valuable information about the mechanisms of action/interaction of new antithrombotic agents. Small and large animal models of thrombosis and their role in the discovery and development of novel agents are described. Methods and major issues regarding the use of animal models of thrombosis, such as positive controls, appropriate pharmacodynamic markers of activity, safety evaluation, species specificity, and pharmacokinetics, are highlighted. Finally, the use of genetic models of thrombosis/hemostasis and how these models have aided in the development of therapies that are presently being evaluated clinically are presented.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Didisheim, P. (1972) Animal models useful in the study of thrombosis and antithrombotic agents Prog Hemost Thromb 1, 165–97.

    PubMed  CAS  Google Scholar 

  2. Leadley, R.J., Jr., Chi, L., Rebello, S.S., and Gagnon, A. (2000) Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents J Pharmacol Toxicol Methods 43, 101–16.

    Article  PubMed  CAS  Google Scholar 

  3. Wessler, S., Reimer, S.M., and Sheps, M.C. (1959) Biologic assay of a thrombosis-inducing activity in human serum J Appl Physiol 14, 943–6.

    PubMed  CAS  Google Scholar 

  4. Meuleman, D.G., Hobbelen, P.M., Van Dinther, T.G., Vogel, G.M., Van Boeckel, C.A., and Moelker, H.C. (1991) Antifactor Xa activity and antithrombotic activity in rats of structural analogues of the minimum antithrombin III binding sequence: discovery of compounds with a longer duration of action than of the natural pentasaccharide Semin Thromb Hemost 17 (Suppl 1), 112–7.

    PubMed  Google Scholar 

  5. Carrie, D., Caranobe, C., Saivin, S., Houin, G., Petitou, M., Lormeau, J.C., Van Boeckel, C., Meuleman, D., and Boneu, B. (1994) Pharmacokinetic and antithrombotic properties of two pentasaccharides with high affinity to antithrombin III in the rabbit: comparison with CY216 Blood 84, 2571–7.

    PubMed  CAS  Google Scholar 

  6. Walenga, J.M., Petitou, M., Lormeau, J.C., Samama, M., Fareed, J., and Choay, J. (1987) Antithrombotic activity of a synthetic heparin pentasaccharide in a rabbit stasis thrombosis model using different thrombogenic challenges Thromb Res 46, 187–98.

    Article  PubMed  CAS  Google Scholar 

  7. Vlasuk, G.P., Ramjit, D., Fujita, T., Dunwiddie, C.T., Nutt, E.M., Smith, D.E., and Shebuski, R.J. (1991) Comparison of the in vivo anticoagulant properties of standard heparin and the highly selective factor Xa inhibitors antistasin and tick anticoagulant peptide (TAP) in a rabbit model of venous thrombosis Thromb Haemost 65, 257–62.

    PubMed  CAS  Google Scholar 

  8. Millet, J., Theveniaux, J., and Brown, N.L. (1994) The venous antithrombotic profile of naroparcil in the rabbit Thromb Haemost 72, 874–9.

    PubMed  CAS  Google Scholar 

  9. Callas, D.D., Bacher, P., and Fareed, J. (1995) Studies on the thrombogenic effects of recombinant tissue factor. In vivo versus ex vivo findings Semin Thromb Hemost 21, 166–76.

    Article  PubMed  CAS  Google Scholar 

  10. Yeghiazarians, Y., Braunstein, J.B., Askari, A., and Stone, P.H. (2000) Unstable angina pectoris N Engl J Med 342, 101–14.

    Article  PubMed  CAS  Google Scholar 

  11. Anderson, H., and Willerson, J. Experimental models of thrombosis. In: Loscalzo, J., and Schafer, A., eds. Thrombosis and Hemorrhage. Boston: Blackwell Scientific; 1994:385–93.

    Google Scholar 

  12. Badimon, L. (1997) Models to study thrombotic disorders Thromb Haemost 78, 667–71.

    PubMed  CAS  Google Scholar 

  13. Bush, L.R., and Shebuski, R.J. (1990) In vivo models of arterial thrombosis and thrombolysis FASEB J 4, 3087–98.

    PubMed  CAS  Google Scholar 

  14. Chi, L., Rebello, S., and Lucchesi, B.R. In vivo models of thrombosis. In: Uprichard, A., and Gallagher, K., eds. Anti-thrombotics. Heidelberg: Springer; 1999:101–27.

    Google Scholar 

  15. Gold, H.K., Yasuda, T., Jang, I.K., Guerrero, J.L., Fallon, J.T., Leinbach, R.C., and Collen, D. (1991) Animal models for arterial thrombolysis and prevention of reocclusion. Erythrocyte-rich versus platelet-rich thrombus Circulation 83, IV26–40.

    PubMed  CAS  Google Scholar 

  16. Bocan, T.M. (1998) Animal models of atherosclerosis and interpretation of drug intervention studies Curr Pharm Des 4, 37–52.

    PubMed  CAS  Google Scholar 

  17. Johnson, G.J., Griggs, T.R., and Badimon, L. (1999) The utility of animal models in the preclinical study of interventions to prevent human coronary artery restenosis: analysis and recommendations. On behalf of the Subcommittee on Animal, Cellular and Molecular Models of Thrombosis and Haemostasis of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis Thromb Haemost 81, 835–43.

    PubMed  CAS  Google Scholar 

  18. Hunter, A.J., Green, A.R., and Cross, A.J. (1995) Animal models of acute ischaemic stroke: can they predict clinically successful neuroprotective drugs? Trends Pharmacol Sci 16, 123–8.

    Article  PubMed  CAS  Google Scholar 

  19. Folts, J.D., Crowell, E.B., Jr., and Rowe, G.G. (1976) Platelet aggregation in partially obstructed vessels and its elimination with aspirin Circulation 54, 365–70.

    Article  PubMed  CAS  Google Scholar 

  20. Golino, P., Ragni, M., Cirillo, P., D’Andrea, D., Scognamiglio, A., Ravera, A., Buono, C., Ezban, M., Corcione, N., Vigorito, F., Condorelli, M., and Chiariello, M. (1998) Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis Circ Res 82,39–46.

    Article  PubMed  CAS  Google Scholar 

  21. Aiken, J.W., Gorman, R.R., and Shebuski, R.J. (1979) Prevention of blockage of partially obstructed coronary arteries with prostacyclin correlates with inhibition of platelet aggregation Prostaglandins 17, 483–94.

    Article  PubMed  CAS  Google Scholar 

  22. Aiken, J.W., Shebuski, R.J., Miller, O.V., and Gorman, R.R. (1981) Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis J Pharmacol Exp Therap 219, 299–308.

    CAS  Google Scholar 

  23. Bush, L.R., Campbell, W.B., Buja, L.M., Tilton, G.D., and Willerson, J.T. (1984) Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries Circulation 69, 1161–70.

    Article  PubMed  CAS  Google Scholar 

  24. Folts, J.D., Gallagher, K., and Rowe, G.G. (1982) Blood flow reductions in stenosed canine coronary arteries: vasospasm or platelet aggregation? Circulation 65, 248–55.

    Article  PubMed  CAS  Google Scholar 

  25. Shebuski, R.J., Ramjit, D.R., Bencen, G.H., and Polokoff, M.A. (1989) Characterization and platelet inhibitory activity of bitistatin, a potent arginine-glycine-aspartic acid-containing peptide from the venom of the viper Bitis arietans J Biol Chem 264, 21550–6.

    PubMed  CAS  Google Scholar 

  26. Shebuski, R.J., Ramjit, D.R., Sitko, G.R., Lumma, P.K., and Garsky, V.M. (1990) Prevention of canine coronary artery thrombosis with echistatin, a potent inhibitor of platelet aggregation from the venom of the viper, Echis carinatus Thromb Haemost 64, 576–81.

    PubMed  CAS  Google Scholar 

  27. Uchida, Y., Yoshimoto, N., and Murao, S. (1975) Cyclic fluctuations in coronary blood pressure and flow induced by coronary artery constriction Jpn Heart J 16, 454–64.

    Article  PubMed  CAS  Google Scholar 

  28. Bush, L.R., and Patrick, D.L. (1986) The role of the endothelium in arterial thrombosis and the influence of antithrombotic therapy Drug Devel Res 7, 319–40.

    Article  CAS  Google Scholar 

  29. Golino, P., Ashton, J.H., Buja, L.M., Rosolowsky, M., Taylor, A.L., McNatt, J., Campbell, W.B., and Willerson, J.T. (1989) Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators Circulation 79, 154–66.

    Article  PubMed  CAS  Google Scholar 

  30. Bush, L.R., Campbell, W.B., Kern, K., Tilton, G.D., Apprill, P., Ashton, J., Schmitz, J., Buja, L.M., and Willerson, J.T. (1984) The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries Circ Res 55, 642–52.

    Article  PubMed  CAS  Google Scholar 

  31. Bennett, J.S., and Vilaire, G. (1979) Exposure of platelet fibrinogen receptors by ADP and epinephrine J Clin Invest 64, 1393–401.

    Article  PubMed  CAS  Google Scholar 

  32. Coller, B.S., and Scudder, L.E. (1985) Inhibition of dog platelet function by in vivo infusion of F(abʹ)2 fragments of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor Blood 66, 1456–9.

    PubMed  CAS  Google Scholar 

  33. Shebuski, R.J., Berry, D.E., Bennett, D.B., Romoff, T., Storer, B.L., Ali, F., and Samanen, J. (1989) Demonstration of Ac-Arg-Gly-Asp-Ser-NH2 as an antiaggregatory agent in the dog by intracoronary administration Thromb Haemost 61, 183–8.

    PubMed  CAS  Google Scholar 

  34. Eidt, J.F., Allison, P., Noble, S., Ashton, J., Golino, P., McNatt, J., Buja, L.M., and Willerson, J.T. (1989) Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury J Clin Invest 84, 18–27.

    Article  PubMed  CAS  Google Scholar 

  35. Smith, J., and Shebuski, R. (1988) Lack of an inhibitory effect of tissue plasminogen activator (t-PA) on platelet aggregation in vivo FASEB J J2, A1164.

    Google Scholar 

  36. Al-Wathiqui, M.H., Hartman, J.C., Brooks, H.L., Gross, G.J., and Warltier, D.C. (1988) Cyclical carotid artery flow reduction in conscious dogs: effect of a new thromboxane receptor antagonist Am Heart J 116, 1482–7.

    Article  PubMed  CAS  Google Scholar 

  37. Gallagher, K.P., Folts, J.D., and Rowe, G.G. (1978) Comparison of coronary arteriograms with direct measurements of stenosed coronary arteries in dogs Am Heart J 95, 338–47.

    Article  PubMed  CAS  Google Scholar 

  38. Schumacher, W.A., Heran, C.L., Goldenberg, H.J., Harris, D.N., and Ogletree, M.L. (1989) Magnitude of thromboxane receptor antagonism necessary for antithrombotic activity in monkeys Am J Physiol 256, H726–34.

    PubMed  CAS  Google Scholar 

  39. Coller, B.S., Folts, J.D., Scudder, L.E., and Smith, S.R. (1986) Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor in an experimental animal model Blood 68, 783–6.

    PubMed  CAS  Google Scholar 

  40. Eidt, J.F., Ashton, J., Golino, P., McNatt, J., Buja, L.M., and Willerson, J.T. (1989) Treadmill exercise promotes cyclic alterations in coronary blood flow in dogs with coronary artery stenoses and endothelial injury J Clin Invest 84, 517–27.

    Article  PubMed  CAS  Google Scholar 

  41. O’Neill, W., Topol, E., and Pitt, B. (1988) Coronary thrombolysis for evolving myocardial infarction Prog Cardiovasc Dis 30, 465–83.

    Article  Google Scholar 

  42. Folts, J., and Rowe, G. (1974) Cyclical reductions in coronary blood flow in coronary arteries with fixed partial obstruction and their inhibition with aspirin Fed Proc 33.

    Google Scholar 

  43. Folts, J.D., and Rowe, G.G. (1988) Epinephrine potentiation of in vivo stimuli reverses aspirin inhibition of platelet thrombus formation in stenosed canine coronary arteries Thromb Res 50, 507–16.

    Article  PubMed  CAS  Google Scholar 

  44. Folts, J. (1991) An in vivo model of experimental arterial stenosis, intimal damage, and periodic thrombosis Circulation 83, IV3–14.

    Article  PubMed  CAS  Google Scholar 

  45. Just, M., Tripier, D., and Seiffge, D. (1991) Antithrombotic effects of recombinant hirudin in different animal models Haemostasis 21(Suppl 1), 80–7.

    PubMed  CAS  Google Scholar 

  46. Apprill, P., Schmitz, J.M., Campbell, W.B., Tilton, G., Ashton, J., Raheja, S., Buja, L.M., and Willerson, J.T. (1985) Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors Circulation 72, 397–405.

    Article  PubMed  CAS  Google Scholar 

  47. Romson, J.L., Hook, B.G., and Lucchesi, B.R. (1983) Potentiation of the antithrombotic effect of prostacyclin by simultaneous administration of aminophylline in a canine model of coronary artery thrombosis J Pharmacol Exp Therap 227, 288–94.

    CAS  Google Scholar 

  48. Just, M., and Schonafinger, K. (1991) Antithrombotic properties of a novel sydnonimine derivative J Cardiovasc Pharmacol 17(Suppl 3), S121–6.

    Article  CAS  Google Scholar 

  49. Mousa, S.A., DeGrado, W.F., Mu, D.X., Kapil, R.P., Lucchesi, B.R., and Reilly, T.M. (1996) Oral antiplatelet, antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa antagonist Circulation 93, 537–43.

    Article  PubMed  CAS  Google Scholar 

  50. Leadley, R.J., Jr., Kasiewski, C.J., Bostwick, J.S., Bentley, R., Dunwiddie, C.T., and Perrone, M.H. (1998) Inhibition of repetitive thrombus formation in the stenosed canine coronary artery by enoxaparin, but not by unfractionated heparin Arterioscl Thromb Vasc Biol 18, 908–14.

    Article  PubMed  CAS  Google Scholar 

  51. Rubsamen, K., and Kirchengast, M. (1998) Thrombin inhibition and intracoronary thrombus formation: effect of polyethylene glycol-coupled hirudin in the stenosed, locally injured canine coronary artery Coron Artery Dis 9, 35–42.

    Article  PubMed  CAS  Google Scholar 

  52. Mehta, J.L., Chen, L., Nichols, W.W., Mattsson, C., Gustafsson, D., and Saldeen, T.G. (1998) Melagatran, an oral active-site inhibitor of thrombin, prevents or delays formation of electrically induced occlusive thrombus in the canine coronary artery J Cardiovasc Pharmacol 31, 345–51.

    Article  PubMed  CAS  Google Scholar 

  53. Ikeda, H., Ueyama, T., Murohara, T., Yasukawa, H., Haramaki, N., Eguchi, H., Katoh, A., Takajo, Y., Onitsuka, I., Ueno, T., Tojo, S.J., and Imaizumi, T. (1999) Adhesive interaction between P-selectin and sialyl Lewis(x) plays an important role in recurrent coronary arterial thrombosis in dogs Arterioscl Thromb Vasc Biol 19, 1083–90.

    Article  PubMed  CAS  Google Scholar 

  54. Jackson, C.V., Bailey, B.D., and Shetler, T.J. (2000) Pharmacological profile of recombinant, human activated protein C (LY203638) in a canine model of coronary artery thrombosis J Pharmacol Exp Therap 295, 967–71.

    CAS  Google Scholar 

  55. Romson, J.L., Haack, D.W., and Lucchesi, B.R. (1980) Electrical induction of coronary artery thrombosis in the ambulatory canine: a model for in vivo evaluation of anti-thrombotic agents Thromb Res 17, 841–53.

    Article  PubMed  CAS  Google Scholar 

  56. Benedict, C.R., Mathew, B., Rex, K.A., Cartwright, J., Jr., and Sordahl, L.A. (1986) Correlation of plasma serotonin changes with platelet aggregation in an in vivo dog model of spontaneous occlusive coronary thrombus formation Circ Res 58, 58–67.

    Article  PubMed  CAS  Google Scholar 

  57. Warltier, D.C., Lamping, K.A., Pelc, L.R., and Gross, G.J. (1987) A canine model of thrombin-induced coronary artery thrombosis: effects of intracoronary streptokinase on regional myocardial blood flow, contractile function, and infarct size J Pharmacol Methods 18, 305–18.

    Article  PubMed  CAS  Google Scholar 

  58. Coller, B.S., Folts, J.D., Smith, S.R., Scudder, L.E., and Jordan, R. (1989) Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors Circulation 80, 1766–74.

    Article  PubMed  CAS  Google Scholar 

  59. Harbauer, G., Hiller, W., and Hellstern, P. An experimental model of venous thrombosis in the rabbit; test of its usefulness with low-dose heparin. In: L, K., ed. Chirurgisches Forum ‘84 für experimentelle und klinische Forschung. Berlin: Springer; 1984: 69–72.

    Google Scholar 

  60. Just, M. Influence of various agents on experimental thrombosis in the rabbit. In: Wenzel, E., Hellstern, P., Morgenstern, E., Kohler, M., von Blohn, G., eds. Rationelle Therapie und Diagnose von hämorrhagischen und thrombophilen Diathesen. Stuttgart: Schattauer Verlag;1986:4.8–4.95.

    Google Scholar 

  61. Bevilacqua, C., Finesso, M., and Prosdocimi, M. (1991) Acute carotid artery occlusive thrombosis and its pharmacological prevention in the rabbit Thromb Res 62, 263–73.

    Article  PubMed  CAS  Google Scholar 

  62. Spokas, E.G., and Wun, T.C. (1992) Venous thrombosis produced in the vena cava of rabbits by vascular damage and stasis J Pharmacol Toxicol Methods 27, 225–32.

    Article  PubMed  CAS  Google Scholar 

  63. Lyle, E.M., Fujita, T., Conner, M.W., Connolly, T.M., Vlasuk, G.P., and Lynch, J.L., Jr. (1995) Effect of inhibitors of factor Xa or platelet adhesion, heparin, and aspirin on platelet deposition in an atherosclerotic rabbit model of angioplasty injury J Pharmacol Toxicol Methods 33, 53–61.

    Article  PubMed  CAS  Google Scholar 

  64. Meng, K. (1975) Tierexperimentelle Untersuchungen zur antithrombotischen Wirkung von Acetylsalicylsäure Therap Ber 47, 69–79.

    Google Scholar 

  65. Meng, K., and Seuter, F. (1977) Effect of acetylsalicylic acid on experimentally induced arterial thrombosis in rats Naunyn-Schmiedeberg’s Arch Pharmacol 301, 115–9.

    Article  CAS  Google Scholar 

  66. Seuter, F., Busse, W.D., Meng, K., Hoffmeister, F., Moller, E., and Horstmann, H. (1979) The antithrombotic activity of BAY g 6575 Arzneimittel-Forschung 29, 54–9.

    PubMed  CAS  Google Scholar 

  67. Salazar, A.E. (1961) Experimental myocardial infarction. Induction of coronary thrombosis in the intact closed-chest dog Circ Res 9, 1351–6.

    Article  PubMed  CAS  Google Scholar 

  68. Schumacher, W.A., Lee, E.C., and Lucchesi, B.R. (1985) Augmentation of streptokinase-induced thrombolysis by heparin and prostacyclin J Cardiovasc Pharmacol 7, 739–46.

    Article  PubMed  CAS  Google Scholar 

  69. van der Giessen, W.J., Harmsen, E., de Tombe, P.P., Hugenholtz, P.G., and Verdouw, P.D. (1988) Coronary thrombolysis with and without nifedipine in pigs Basic Res Cardiol 83, 258–67.

    Article  PubMed  Google Scholar 

  70. Shea, M.J., Driscoll, E.M., Romson, J.L., Pitt, B., and Lucchesi, B.R. (1984) Effect of OKY-1581, a thromboxane synthetase inhibitor, on coronary thrombosis in the conscious dog Eur J Pharmacol 105, 285–91.

    Article  PubMed  CAS  Google Scholar 

  71. Simpson, P.J., Smith, C.B., Jr., Rosenthal, G., and Lucchesi, B.R. (1986) Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury J Pharmacol Exp Therap 238, 497–501.

    CAS  Google Scholar 

  72. Hook, B.G., Schumacher, W.A., Lee, D.L., Jolly, S.R., and Lucchesi, B.R. (1985) Experimental coronary artery thrombosis in the absence of thromboxane A2 synthesis: evidence for alternate pathways for coronary thrombosis J Cardiovasc Pharmacol 7, 174–81.

    Article  PubMed  CAS  Google Scholar 

  73. Schumacher, W.A., and Lucchesi, B.R. (1983) Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivity J Pharmacol Exp Therap 227, 790–6.

    CAS  Google Scholar 

  74. Fitzgerald, D.J., Fragetta, J., and FitzGerald, G.A. (1988) Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis J Clin Invest 82, 1708–13.

    Article  PubMed  CAS  Google Scholar 

  75. Mickelson, J.K., Simpson, P.J., and Lucchesi, B.R. (1989) Antiplatelet monoclonal F(abʹ)2 antibody directed against the platelet GPIIb/IIIa receptor complex prevents coronary artery thrombosis in the canine heart J Mol Cell Cardiol 21, 393–405.

    Article  PubMed  CAS  Google Scholar 

  76. Shebuski, R.J., Smith, J.M., Jr., Storer, B.L., Granett, J.R., and Bugelski, P.J. (1988) Influence of selective endoperoxide/thromboxane A2 receptor antagonism with sulotroban on lysis time and reocclusion rate after tissue plasminogen activator-induced coronary thrombolysis in the dog J Pharmacol Exp Therap 246, 790–6.

    CAS  Google Scholar 

  77. van der Giessen, W.J., Zijlstra, F.J., Berk, L., and Verdouw, P.D. (1988) The effect of the thromboxane receptor antagonist BM 13.177 on experimentally induced coronary artery thrombosis in the pig Eur J Pharmacol 147, 241–8.

    Article  PubMed  Google Scholar 

  78. Patterson, E., Eller, B.T., Abrams, G.D., Vasiliades, J., and Lucchesi, B.R. (1983) Ventricular fibrillation in a conscious canine preparation of sudden coronary death–prevention by short- and long-term amiodarone administration Circulation 68, 857–64.

    Article  PubMed  CAS  Google Scholar 

  79. Lefkovits, J., Malycky, J.L., Rao, J.S., Hart, C.E., Plow, E.F., Topol, E.J., and Nicolini, F.A. (1996) Selective inhibition of factor Xa is more efficient than factor VIIa-tissue factor complex blockade at facilitating coronary thrombolysis in the canine model J Am Coll Cardiol 28, 1858–65.

    Article  PubMed  CAS  Google Scholar 

  80. Lynch, J.J., Jr., Sitko, G.R., Mellott, M.J., Nutt, E.M., Lehman, E.D., Friedman, P.A., Dunwiddie, C.T., and Vlasuk, G.P. (1994) Maintenance of canine coronary artery patency following thrombolysis with front loaded plus low dose maintenance conjunctive therapy. A comparison of factor Xa versus thrombin inhibition Cardiovasc Res 28, 78–85.

    Article  PubMed  CAS  Google Scholar 

  81. Nicolini, F.A., Lee, P., Rios, G., Kottke-Marchant, K., and Topol, E.J. (1994) Combination of platelet fibrinogen receptor antagonist and direct thrombin inhibitor at low doses markedly improves thrombolysis Circulation 89, 1802–9.

    Article  PubMed  CAS  Google Scholar 

  82. Sitko, G.R., Ramjit, D.R., Stabilito, II, Lehman, D., Lynch, J.J., and Vlasuk, G.P. (1992) Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis Circulation 85, 805–15.

    Article  PubMed  CAS  Google Scholar 

  83. Waxman, L., Smith, D.E., Arcuri, K.E., and Vlasuk, G.P. (1990) Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa Science 248, 593–6.

    Article  PubMed  CAS  Google Scholar 

  84. Lutz, B.R., Fulton, G.P., and Akers, R.P. (1951) White thromboembolism in the hamster cheek pouch after trauma, infection and neoplasia Circulation 3, 339–51.

    Article  PubMed  CAS  Google Scholar 

  85. Sawyer, P.N., and Pate, J.W. (1953) Bio-electric phenomena as an etiologic factor in intravascular thrombosis Am J Physiol 175, 103–7.

    PubMed  CAS  Google Scholar 

  86. Sawyer, P.N., Pate, J.W., and Weldon, C.S. (1953) Relations of abnormal and injury electric potential differences to intravascular thrombosis Am J Physiol 175, 108–12.

    PubMed  CAS  Google Scholar 

  87. Hladovec, J. (1971) Experimental arterial thrombosis in rats with continuous registration Thromb Diath Haemorrh 26, 407–10.

    PubMed  CAS  Google Scholar 

  88. Philp, R.B., Francey, I., and Warren, B.A. (1978) Comparison of antithrombotic activity of heparin, ASA, sulfinpyrazone and VK 744 in a rat model of arterial thrombosis Haemostasis 7, 282–93.

    PubMed  CAS  Google Scholar 

  89. Rote, W.E., Mu, D.X., Roncinske, R.A., Frelinger, A.L., 3rd, and Lucchesi, B.R. (1993) Prevention of experimental carotid artery thrombosis by applaggin J Pharmacol Exp Therap 267, 809–14.

    CAS  Google Scholar 

  90. Rote, W.E., Davis, J.H., Mousa, S.A., Reilly, T.M., and Lucchesi, B.R. (1994) Antithrombotic effects of DMP 728, a platelet GPIIb/IIIa receptor antagonist, in a canine model of arterial thrombosis J Cardiovasc Pharmacol 23, 681–9.

    Article  PubMed  CAS  Google Scholar 

  91. Schumacher, W.A., Heran, C.L., and Steinbacher, T.E. (1996) Low-molecular-weight heparin (fragmin) and thrombin active-site inhibitor (argatroban) compared in experimental arterial and venous thrombosis and bleeding time J Cardiovasc Pharmacol 28, 19–25.

    Article  PubMed  CAS  Google Scholar 

  92. Guarini, S. (1996) A highly reproducible model of arterial thrombosis in rats J Pharmacol Toxicol Methods 35, 101–5.

    Article  PubMed  CAS  Google Scholar 

  93. Kurz, K.D., Main, B.W., and Sandusky, G.E. (1990) Rat model of arterial thrombosis induced by ferric chloride Thromb Res 60, 269–80.

    Article  PubMed  CAS  Google Scholar 

  94. Deschenes, I., Finkle, C.D., and Winocour, P.D. (1998) Effective use of BCH-2763, a new potent injectable direct thrombin inhibitor, in combination with tissue plasminogen activator (tPA) in a rat arterial thrombolysis model Thromb Haemost 80, 186–91.

    PubMed  CAS  Google Scholar 

  95. Elg, M., Gustafsson, D., and Carlsson, S. (1999) Antithrombotic effects and bleeding time of thrombin inhibitors and warfarin in the rat Thromb Res 94, 187–97.

    Article  PubMed  CAS  Google Scholar 

  96. Schumacher, W.A., Heran, C.L., Steinbacher, T.E., Youssef, S., and Ogletree, M.L. (1993) Superior activity of a thromboxane receptor antagonist as compared with aspirin in rat models of arterial and venous thrombosis J Cardiovasc Pharmacol 22, 526–33.

    Article  PubMed  CAS  Google Scholar 

  97. Roesken, F., Ruecker, M., Vollmar, B., Boeckel, N., Morgenstern, E., and Menger, M.D. (1997) A new model for quantitative in vivo microscopic analysis of thrombus formation and vascular recanalisation: the ear of the hairless (hr/hr) mouse Thromb Haemost 78, 1408–14.

    PubMed  CAS  Google Scholar 

  98. Saniabadi, A.R., Umemura, K., Matsumoto, N., Sakuma, S., and Nakashima, M. (1995) Vessel wall injury and arterial thrombosis induced by a photochemical reaction Thromb Haemost 73, 868–72.

    PubMed  CAS  Google Scholar 

  99. Hokamura, K., Umemura, K., Nakamura, N., Watanabe, M., Takashima, T., and Nakashima, M. (1998) Effect of lipo-pro-prostaglandin E1, AS-013 on rat inner ear microcirculatory thrombosis Prostaglandins Leukot Essent Fatty Acids 59, 203–7.

    Article  PubMed  CAS  Google Scholar 

  100. Reimann-Hunziger, G. (1944) Über experimentelle Thrombose und ihre Behandlung mit Heparin Schweiz Med Wschr 74, 66–9.

    Google Scholar 

  101. Broersma, R.J., Kutcher, L.W., and Heminger, E.F. (1991) The effect of thrombin inhibition in a rat arterial thrombosis model Thromb Res 64, 405–12.

    Article  PubMed  CAS  Google Scholar 

  102. van Giezen, J.J., Wahlund, G., Nerme, and Abrahamsson, T. (1997) The Fab-fragment of a PAI-1 inhibiting antibody reduces thrombus size and restores blood flow in a rat model of arterial thrombosis Thromb Haemost 77, 964–9.

    PubMed  Google Scholar 

  103. Shebuski, R.J., Storer, B.L., and Fujita, T. (1988) Effect of thromboxane synthase inhibition on the thrombolytic action of tissue-type plasminogen activator in a rabbit model of peripheral arterial thrombosis Thromb Res 52, 381–92.

    Article  PubMed  CAS  Google Scholar 

  104. Gold, H.K., Fallon, J.T., Yasuda, T., Leinbach, R.C., Khaw, B.A., Newell, J.B., Guerrero, J.L., Vislosky, F.M., Hoyng, C.F., and Grossbard, E., et al. (1984) Coronary thrombolysis with recombinant human tissue-type plasminogen activator Circulation 70, 700–7.

    Article  PubMed  CAS  Google Scholar 

  105. Collen, D., Stassen, J.M., and Verstraete, M. (1983) Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration J Clin Invest 71, 368–76.

    Article  PubMed  CAS  Google Scholar 

  106. Kopia, G.A., Kopaciewicz, L.J., and Ruffolo, R.R., Jr. (1988) Coronary thrombolysis with intravenous streptokinase in the anesthetized dog: a dose-response study J Pharmacol Exp Therap 244, 956–62.

    CAS  Google Scholar 

  107. Gold, H.K., Leinbach, R.C., Garabedian, H.D., Yasuda, T., Johns, J.A., Grossbard, E.B., Palacios, I., and Collen, D. (1986) Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion Circulation 73, 347–52.

    Article  PubMed  CAS  Google Scholar 

  108. Gold, H.K., Coller, B.S., Yasuda, T., Saito, T., Fallon, J.T., Guerrero, J.L., Leinbach, R.C., Ziskind, A.A., and Collen, D. (1988) Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation Circulation 77, 670–7.

    Article  PubMed  CAS  Google Scholar 

  109. Goldberg, R.K., Levine, S., and Fenster, P.E. (1985) Management of patients after thrombolytic therapy for acute myocardial infarction Clin Cardiol 8, 455–9.

    Article  PubMed  CAS  Google Scholar 

  110. Coller, B.S., Peerschke, E.I., Scudder, L.E., and Sullivan, C.A. (1983) A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa J Clin Invest 72, 325–38.

    Article  PubMed  CAS  Google Scholar 

  111. Yasuda, T., Gold, H.K., Fallon, J.T., Leinbach, R.C., Guerrero, J.L., Scudder, L.E., Kanke, M., Shealy, D., Ross, M.J., and Collen, D., et al. (1988) Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs J Clin Invest 81, 1284–91.

    Article  PubMed  CAS  Google Scholar 

  112. Weichert, W., and Breddin, H.K. (1988) Effect of low-molecular-weight heparins on laser-induced thrombus formation in rat mesenteric vessels Haemostasis 18(Suppl 3), 55–63.

    PubMed  CAS  Google Scholar 

  113. Arfors, K.E., Dhall, D.P., Engeset, J., Hint, H., Matheson, N.A., and Tangen, O. (1968) Biolaser endothelial trauma as a means of quantifying platelet activity in vivo Nature 218, 887–8.

    Article  Google Scholar 

  114. Herrmann, K.S. (1983) Platelet aggregation induced in the hamster cheek pouch by a photochemical process with excited fluorescein isothiocyanate-dextran Microvasc Res 26, 238–49.

    Article  PubMed  CAS  Google Scholar 

  115. Seiffge, D., and Kremer, E. (1984) Antithrombotic effects of pentoxifylline on laser-induced thrombi in rat mesenteric arteries IRCS Med Sci 12, 91–2.

    CAS  Google Scholar 

  116. Seiffge, D., and Kremer, E. (1986) Influence of ADP, blood flow velocity, and vessel diameter on the laser-induced thrombus formation Thromb Res 42, 331–41.

    Article  PubMed  CAS  Google Scholar 

  117. Seiffge, D., and Weithmann, K.U. (1987) Surprising effects of the sequential administration of pentoxifylline and low dose acetylsalicylic acid on thrombus formation Thromb Res 46, 371–83.

    Article  PubMed  CAS  Google Scholar 

  118. Weichert, W., Pauliks, V., and Breddin, H.K. (1983) Laser-induced thrombi in rat mesenteric vessels and antithrombotic drugs Haemostasis 13, 61–71.

    PubMed  CAS  Google Scholar 

  119. Rosenblum, W.I., and El-Sabban, F. (1977) Platelet aggregation in the cerebral microcirculation: effect of aspirin and other agents Circ Res 40, 320–8.

    Article  PubMed  CAS  Google Scholar 

  120. Matsuno, H., Uematsu, T., Nagashima, S., and Nakashima, M. (1991) Photochemically induced thrombosis model in rat femoral artery and evaluation of effects of heparin and tissue-type plasminogen activator with use of this model J Pharmacol Methods 25, 303–17.

    Article  PubMed  CAS  Google Scholar 

  121. Stone, P., and Lord, J.W., Jr. (1951) An experimental study of the thrombogenic properties of magnesium and magnesium-aluminum wire in the dog’s aorta Surgery 30, 987–93.

    PubMed  CAS  Google Scholar 

  122. Mellott, M.J., Stranieri, M.T., Sitko, G.R., Stabilito, I.I., Lynch Jr, J.J., and Vlasuk, G.P. (1993) Enhancement of recombinant tissue plasminogen activator-induced reperfusion by recombinant tick anticoagulant peptide, a selective factor Xa inhibitor, in a canine model of femoral arterial thrombosis Fibrinolysis 7, 195–202.

    Article  CAS  Google Scholar 

  123. Rubsamen, K., and Hornberger, W. (1996) Prevention of early reocclusion after thrombolysis of copper coil-induced thrombi in the canine carotid artery: comparison of PEG-hirudin and unfractionated heparin Thromb Haemost 76, 105–10.

    PubMed  CAS  Google Scholar 

  124. Kumada, T., Ishihara, M., Ogawa, H., and Abiko, Y. (1980) Experimental model of venous thrombosis in rats and effect of some agents Thromb Res 18, 189–203.

    Article  PubMed  CAS  Google Scholar 

  125. Bernat, A., Vallee, E., and Maffrand, J. (1986) A simple experimental model of thrombolysis in the rat: effect of urokinase and of the complex human plasminogen-streptokinase Thromb Res 44, 112.

    Article  Google Scholar 

  126. Hergrueter, C.A., Handren, J., Kersh, R., and May, J.W., Jr. (1988) Human recombinant tissue type plasminogen activator and its effect on microvascular thrombosis in the rabbit Plast Reconstruct Surg 81, 418–24.

    Article  CAS  Google Scholar 

  127. Jang, I.K., Gold, H.K., Ziskind, A.A., Fallon, J.T., Holt, R.E., Leinbach, R.C., May, J.W., and Collen, D. (1989) Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysis Circulation 79, 920–8.

    Article  PubMed  CAS  Google Scholar 

  128. Jang, I.K., Gold, H.K., Ziskind, A.A., Leinbach, R.C., Fallon, J.T., and Collen, D. (1990) Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition Circulation 81, 219–25.

    Article  PubMed  CAS  Google Scholar 

  129. Kaiser, B., and Fareed, J. (1996) Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis Thromb Haemost 76, 615–20.

    PubMed  CAS  Google Scholar 

  130. Kaiser, B., Simon, A., and Markwardt, F. (1990) Antithrombotic effects of recombinant hirudin in experimental angioplasty and intravascular thrombolysis Thromb Haemost 63, 44–7.

    PubMed  CAS  Google Scholar 

  131. Katsuragawa, M., Fujiwara, H., Kawamura, A., Htay, T., Yoshikuni, Y., Mori, K., and Sasayama, S. (1993) An animal model of coronary thrombosis and thrombolysis—comparisons of vascular damage and thrombus formation in the coronary and femoral arteries after balloon angioplasty Jpn Circ J 57, 1000–6.

    Article  PubMed  CAS  Google Scholar 

  132. Kaiser, B., and Markwardt, F. (1986) Experimental studies on the antithrombotic action of a highly effective synthetic thrombin inhibitor Thromb Haemost 55, 194–6.

    PubMed  CAS  Google Scholar 

  133. Heras, M., Chesebro, J.H., Penny, W.J., Bailey, K.R., Lam, J.Y., Holmes, D.R., Reeder, G.S., Badimon, L., and Fuster, V. (1988) Importance of adequate heparin dosage in arterial angioplasty in a porcine model Circulation 78, 654–60.

    Article  PubMed  CAS  Google Scholar 

  134. Harker, L.A. (1987) Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty Am J Cardiol 60, 20B–8B.

    Article  PubMed  CAS  Google Scholar 

  135. Rowntree, L., and Shionoya, T. (1927) Studies in extracorporeal thrombosis. I. A method for the direct observation of extracorporal thrombus formation. II. Thrombosis formation in normal blood in the extracorporeal vascular loop. III. Effects of certain anticoagulants (heparin and hirudin) on extracorporeal thrombosis and on the mechanism of thrombus formation J Exp Med 46, 7–26.

    Article  PubMed  CAS  Google Scholar 

  136. Knabb, R.M., Kettner, C.A., Timmermans, P.B., and Reilly, T.M. (1992) In vivo characterization of a new synthetic thrombin inhibitor Thromb Haemost 67, 56–9.

    PubMed  CAS  Google Scholar 

  137. Hara, T., Yokoyama, A., Tanabe, K., Ishihara, H., and Iwamoto, M. (1995) DX-9065a, an orally active, specific inhibitor of factor Xa, inhibits thrombosis without affecting bleeding time in rats Thromb Haemost 74, 635–9.

    PubMed  CAS  Google Scholar 

  138. Scott, N.A., Nunes, G.L., King, S.B., 3rd, Harker, L.A., and Hanson, S.R. (1994) Local delivery of an antithrombin inhibits platelet-dependent thrombosis Circulation 90, 1951–5.

    Article  PubMed  CAS  Google Scholar 

  139. Best, C.H., Cowan, C., and Maclean, D.L. (1938) Heparin and the formation of white thrombi J Physiol 92, 20–31.

    PubMed  CAS  Google Scholar 

  140. Yokoyama, T., Kelly, A.B., Marzec, U.M., Hanson, S.R., Kunitada, S., and Harker, L.A. (1995) Antithrombotic effects of orally active synthetic antagonist of activated factor X in nonhuman primates Circulation 92, 485–91.

    Article  PubMed  CAS  Google Scholar 

  141. Hollenbach, S., Wong, A., Ku, P., Needham, K., Lin, P.H., and Sinha, U. (1995) Efficacy of FXa inhibitors in a rabbit model of venous thrombosis Circulation 92, I486–7.

    Google Scholar 

  142. Hollenbach, S., Sinha, U., Lin, P.H., Needham, K., Frey, L., Hancock, T., Wong, A., and Wolf, D. (1994) A comparative study of prothrombinase and thrombin inhibitors in a novel rabbit model of non-occlusive deep vein thrombosis Thromb Haemost 71, 357–62.

    PubMed  CAS  Google Scholar 

  143. Gryglewski, R.J., Korbut, R., Ocetkiewicz, A., and Stachura, J. (1978) In vivo method for quantitation for anti-platelet potency of drugs Naunyn-Schmiedeberg’s Arch Pharmacol 302, 25–30.

    Article  CAS  Google Scholar 

  144. Wessler, S. (1952) Studies in intravascular coagulation. I. Coagulation changes in isolated venous segments J Clin Invest 31, 1011–4.

    Article  PubMed  CAS  Google Scholar 

  145. Wessler, S. (1953) Studies in intravascular coagulation. II. A comparison of the effect of dicumarol and heparin on clot formation in isolated venous segments J Clin Invest 32, 650–4.

    Article  PubMed  CAS  Google Scholar 

  146. Wessler, S. (1955) Studies in intravascular coagulation. III. The pathogenesis of serum-induced venous thrombosis J Clin Invest 34, 647–51.

    Article  PubMed  CAS  Google Scholar 

  147. Wessler, S., Ballon, J.D., and Katz, J.H. (1957) Studies in intravascular coagulation. V. A distinction between the anticoagulant and antithrombotic effects of dicumarol N Engl J Med 256, 1223–5.

    Article  PubMed  CAS  Google Scholar 

  148. Wessler, S., and Morris, L.E. (1955) Studies in intravascular coagulation. IV. The effect of heparin and dicumarol on serum-induced venous thrombosis Circulation 12, 553–6.

    Article  PubMed  CAS  Google Scholar 

  149. Fareed, J., Walenga, J.M., Kumar, A., and Rock, A. (1985) A modified stasis thrombosis model to study the antithrombotic actions of heparin and its fractions Semin Thromb Hemost 11, 155–75.

    Article  PubMed  CAS  Google Scholar 

  150. Aronson, D.L., and Thomas, D.P. (1985) Experimental studies on venous thrombosis: effect of coagulants, procoagulants and vessel contusion Thromb Haemost 54, 866–70.

    PubMed  CAS  Google Scholar 

  151. Breddin, H.K. (1989) Thrombosis and Virchow’s triad: what is established? Semin Thromb Hemost 15, 237–9.

    Article  PubMed  CAS  Google Scholar 

  152. Levi, M., Biemond, B.J., van Zonneveld, A.J., ten Cate, J.W., and Pannekoek, H. (1992) Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis Circulation 85, 305–12.

    Article  PubMed  CAS  Google Scholar 

  153. Biemond, B.J., Friederich, P.W., Levi, M., Vlasuk, G.P., Buller, H.R., and ten Cate, J.W. (1996) Comparison of sustained antithrombotic effects of inhibitors of thrombin and factor Xa in experimental thrombosis Circulation 93, 153–60.

    Article  PubMed  CAS  Google Scholar 

  154. Herbert, J.M., Bernat, A., Dol, F., Herault, J.P., Crepon, B., and Lormeau, J.C. (1996) DX 9065A a novel, synthetic, selective and orally active inhibitor of factor Xa: in vitro and in vivo studies J Pharmacol Exp Therap 276, 1030–8.

    CAS  Google Scholar 

  155. Sato, K., Kawasaki, T., Hisamichi, N., Taniuchi, Y., Hirayama, F., Koshio, H., and Matsumoto, Y. (1998) Antithrombotic effects of YM-60828, a newly synthesized factor Xa inhibitor, in rat thrombosis models and its effects on bleeding time Br J Pharmacol 123, 92–6.

    Article  PubMed  CAS  Google Scholar 

  156. Yamazaki, M., Asakura, H., Aoshima, K., Saito, M., Jokaji, H., Uotani, C., Kumabashiri, I., Morishita, E., Ikeda, T., and Matsuda, T. (1994) Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats Thromb Haemost 72, 392–6.

    PubMed  CAS  Google Scholar 

  157. Fu, K., Izquierdo, R., Vandevender, D., Warpeha, R.L., Wolf, H., and Fareed, J. (1997) Topical application of low molecular weight heparin in a rabbit traumatic anastomosis model Thromb Res 86, 355–61.

    Article  PubMed  CAS  Google Scholar 

  158. Korompilias, A.V., Chen, L.E., Seaber, A.V., and Urbaniak, J.R. (1997) Antithrombotic potencies of enoxaparin in microvascular surgery: influence of dose and administration methods on patency rate of crushed arterial anastomoses J Hand Surg 22, 540–6.

    Article  CAS  Google Scholar 

  159. Stockmans, F., Stassen, J.M., Vermylen, J., Hoylaerts, M.F., and Nystrom, A. (1997) A technique to investigate mural thrombus formation in small arteries and veins: I. Comparative morphometric and histological analysis Ann Plast Surg 38, 56–62.

    Article  PubMed  CAS  Google Scholar 

  160. van Wyk, V., Neethling, W.M., Badenhorst, P.N., and Kotze, H.F. (1998) r-Hirudin inhibits platelet-dependent thrombosis during cardiopulmonary bypass in baboons J Cardiovasc Surg 39, 633–9.

    Google Scholar 

  161. Dewanjee, M.K., Wu, S.M., Kapadvanjwala, M., De, D., Dewanjee, S., Novak, S., Hsu, L.C., Perryman, R.A., Serafini, A.N., Sfakianakis, G.N., Duncan, R.C., Dietrich, W.D., and Horton, A.F. (1996) Reduction of platelet thrombi and emboli by L-arginine during cardiopulmonary bypass in a pig model J Thromb Thrombolysis 3, 343–60.

    PubMed  CAS  Google Scholar 

  162. Henny, C.P., Ten Cate, H., Ten Cate, J.W., Moulijn, A.C., Sie, T.H., Warren, P., and Buller, H.R. (1985) A randomized blind study comparing standard heparin and a new low molecular weight heparinoid in cardiopulmonary bypass surgery in dogs J Lab Clin Med 106, 187–96.

    PubMed  CAS  Google Scholar 

  163. Murray, W. A preliminary study of low molecular weight heparin in aortocoronay bypass surgery. In: Murray, W., ed. Low Molecular Weight Heparin in Surgical Practice (Master of Surgery Thesis). London: University of London;1985:266.

    Google Scholar 

  164. Badimon, L., and Badimon, J.J. (1989) Mechanisms of arterial thrombosis in nonparallel streamlines: platelet thrombi grow on the apex of stenotic severely injured vessel wall. Experimental study in the pig model J Clin Invest 84, 1134–44.

    Article  PubMed  CAS  Google Scholar 

  165. Wysokinski, W., McBane, R., Chesebro, J.H., and Owen, W.G. (1996) Reversibility of platelet thrombosis in vivo. Quantitative analysis in porcine carotid arteries Thromb Haemost 76, 1108–13.

    PubMed  CAS  Google Scholar 

  166. Dangas, G., Badimon, J.J., Coller, B.S., Fallon, J.T., Sharma, S.K., Hayes, R.M., Meraj, P., Ambrose, J.A., and Marmur, J.D. (1998) Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab Arterioscler Thromb Vasc Biol 18, 1342–9.

    Article  PubMed  CAS  Google Scholar 

  167. Ørvim, U., Barstad R.M., Vlasuk., G.P., and Sakariassen, K.S. (1995) Effect of selective factor Xa inhibition on arterial thrombus formation triggered by tissue factor/factor VIIa or collagen in an ex vivo model of shear-dependent human thrombogenesis Arterioscler Thromb Vasc Biol 15, 2188–94.

    Article  PubMed  Google Scholar 

  168. Angelillo-Scherrer, A., de Frutos, P., Aparicio, C., Melis, E., Savi, P., Lupu, F., Arnout, J., Dewerchin, M., Hoylaerts, M., Herbert, J., Collen, D., Dahlback, B., and Carmeliet, P. (2001) Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis Nat Med 7, 215–21.

    Article  PubMed  CAS  Google Scholar 

  169. Yang, J., Wu, J., Kowalska, M.A., Dalvi, A., Prevost, N., O’Brien, P.J., Manning, D., Poncz, M., Lucki, I., Blendy, J.A., and Brass, L.F. (2000) Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs Proc Natl Acad Sci USA 97, 9984–9.

    Article  PubMed  CAS  Google Scholar 

  170. Volkl, K.P., and Dierichs, R. (1986) Effect of intravenously injected collagenase on the concentration of circulating platelets in rats Thromb Res 42, 11–20.

    Article  PubMed  CAS  Google Scholar 

  171. Oyekan, A.O., and Botting, J.H. (1986) A minimally invasive technique for the study of intravascular platelet aggregation in anesthetized rats J Pharmacol Methods 15, 271–7.

    Article  PubMed  CAS  Google Scholar 

  172. Smith, D., Sanjar, S., Herd, C., and Morley, J. (1989) In vivo method for the assessment of platelet accumulation J Pharmacol Methods 21, 45–59.

    Article  PubMed  CAS  Google Scholar 

  173. Dottl, K., and Ripke, O. Blutgerinnung und Blutungszeit. In: Medizin und Chemie. Leverkusen: Bayer;1936:267–73.

    Google Scholar 

  174. Dejana, E., Callioni, A., Quintana, A., and de Gaetano, G. (1979) Bleeding time in laboratory animals. II—A comparison of different assay conditions in rats Thromb Res 15, 191–7.

    Article  PubMed  CAS  Google Scholar 

  175. Minsker, D.H., and Kling, P.J. (1977) Bleeding time in rats is prolonged by aspirin Thromb Res 10, 619–22.

    Article  PubMed  CAS  Google Scholar 

  176. Stella, L., Donati, M.B., and de Gaetano, G. (1975) Bleeding time in laboratory animals I. Aspirin does not prolong bleeding time in rats Thromb Res 7, 709–16.

    Article  PubMed  CAS  Google Scholar 

  177. Butler, K.D., Maguire, E.D., Smith, J.R., Turnbull, A.A., Wallis, R.B., and White, A.M. (1982) Prolongation of rat tail bleeding time caused by oral doses of a thromboxane synthetase inhibitor which have little effect on platelet aggregation Thromb Haemost 47, 46–9.

    PubMed  CAS  Google Scholar 

  178. Zawilska, K.M., Born, G.V., and Begent, N.A. (1982) Effect of ADP-utilizing enzymes on the arterial bleeding time in rats and rabbits Br J Haematol 50, 317–25.

    Article  PubMed  CAS  Google Scholar 

  179. Forsythe, L.T., and Willis, S.E. (1989) Evaluating oral mucosa bleeding times in healthy dogs using a spring-loaded device Can Veter J 30, 344–5.

    CAS  Google Scholar 

  180. Klement, P., Liao, P., Hirsh, J., Johnston, M., and Weitz, J.I. (1998) Hirudin causes more bleeding than heparin in a rabbit ear bleeding model J Lab Clin Med 132, 181–5.

    Article  PubMed  CAS  Google Scholar 

  181. Brassard, J.A., and Meyers, K.M. (1991) Evaluation of the buccal bleeding time and platelet glass bead retention as assays of hemostasis in the dog: the effects of acetylsalicylic acid, warfarin and von Willebrand factor deficiency Thromb Haemost 65, 191–5.

    PubMed  CAS  Google Scholar 

  182. Lind, S.E. (1991) The bleeding time does not predict surgical bleeding Blood 77, 2547–52.

    PubMed  CAS  Google Scholar 

  183. Giles, A.R., Tinlin, S., and Greenwood, R. (1982) A canine model of hemophilic (factor VIII: C deficiency) bleeding Blood 60, 727–30.

    PubMed  CAS  Google Scholar 

  184. Carmeliet, P., and Collen, D. New developments in the molecular biology of coagulation and fibrinolysis. In: Handbook of Experimental Pharmacology, Vol 132, Antithrombotics. Berlin: Springer-Verlag;1999:41–76.

    Google Scholar 

  185. Pearson, J., and Ginsburg, D. Use of transgenic mice in the study of thrombosis and hemostasis. In: Handbook of Experimental Pharmacology, Vol 132, Antithrombotics. Berlin: Springer-Verlag; 1999:157–74.

    Google Scholar 

  186. Bi, L., Sarkar, R., Naas, T., Lawler, A.M., Pain, J., Shumaker, S.L., Bedian, V., and Kazazian, H.H., Jr. (1996) Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies Blood 88, 3446–50.

    PubMed  CAS  Google Scholar 

  187. Denis, C., Methia, N., Frenette, P.S., Rayburn, H., Ullman-Cullere, M., Hynes, R.O., and Wagner, D.D. (1998) A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis Proc Natl Acad Sci USA 95, 9524–9.

    Article  PubMed  CAS  Google Scholar 

  188. Hodivala-Dilke, K.M., McHugh, K.P., Tsakiris, D.A., Rayburn, H., Crowley, D., Ullman-Cullere, M., Ross, F.P., Coller, B.S., Teitelbaum, S., and Hynes, R.O. (1999) Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival J Clin Invest 103, 229–38.

    Article  PubMed  CAS  Google Scholar 

  189. Wang, L., Zoppe, M., Hackeng, T.M., Griffin, J.H., Lee, K.F., and Verma, I.M. (1997) A factor IX-deficient mouse model for hemophilia B gene therapy Proc Natl Acad Sci USA 94, 11563–6.

    Article  PubMed  CAS  Google Scholar 

  190. Offermanns, S., Toombs, C.F., Hu, Y.H., and Simon, M.I. (1997) Defective platelet activation in G alpha(q)-deficient mice Nature 389, 183–6.

    Article  PubMed  CAS  Google Scholar 

  191. Law, D.A., DeGuzman, F.R., Heiser, P., Ministri-Madrid, K., Killeen, N., and Phillips, D.R. (1999) Integrin cytoplasmic tyrosine motif is required for outside-in alphaIIbbeta3 signalling and platelet function Nature 401, 808–11.

    Article  PubMed  CAS  Google Scholar 

  192. Kahn, M.L., Zheng, Y.W., Huang, W., Bigornia, V., Zeng, D., Moff, S., Farese, R.V., Jr., Tam, C., and Coughlin, S.R. (1998) A dual thrombin receptor system for platelet activation Nature 394, 690–4.

    Article  PubMed  CAS  Google Scholar 

  193. Leon, C., Hechler, B., Freund, M., Eckly, A., Vial, C., Ohlmann, P., Dierich, A., LeMeur, M., Cazenave, J.P., and Gachet, C. (1999) Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice J Clin Invest 104, 1731–7.

    Article  PubMed  CAS  Google Scholar 

  194. Subramaniam, M., Frenette, P.S., Saffaripour, S., Johnson, R.C., Hynes, R.O., and Wagner, D.D. (1996) Defects in hemostasis in P-selectin-deficient mice Blood 87, 1238–42.

    PubMed  CAS  Google Scholar 

  195. Thomas, D.W., Mannon, R.B., Mannon, P.J., Latour, A., Oliver, J.A., Hoffman, M., Smithies, O., Koller, B.H., and Coffman, T.M. (1998) Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2 J Clin Invest 102, 1994–2001.

    Article  PubMed  CAS  Google Scholar 

  196. Bugge, T.H., Flick, M.J., Daugherty, C.C., and Degen, J.L. (1995) Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction Genes Develop 9, 794–807.

    Article  PubMed  CAS  Google Scholar 

  197. Ploplis, V.A., Carmeliet, P., Vazirzadeh, S., Van Vlaenderen, I., Moons, L., Plow, E.F., and Collen, D. (1995) Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice Circulation 92, 2585–93.

    Article  PubMed  CAS  Google Scholar 

  198. Carmeliet, P., Schoonjans, L., Kieckens, L., Ream, B., Degen, J., Bronson, R., De Vos, R., van den Oord, J.J., Collen, D., and Mulligan, R.C. (1994) Physiological consequences of loss of plasminogen activator gene function in mice Nature 368, 419–24.

    Article  PubMed  CAS  Google Scholar 

  199. Christie, P.D., Edelberg, J.M., Picard, M.H., Foulkes, A.S., Mamuya, W., Weiler-Guettler, H., Rubin, R.H., Gilbert, P., and Rosenberg, R.D. (1999) A murine model of myocardial microvascular thrombosis J Clin Invest 104, 533–9.

    Article  PubMed  CAS  Google Scholar 

  200. Carmeliet, P., Stassen, J.M., Schoonjans, L., Ream, B., van den Oord, J.J., De Mol, M., Mulligan, R.C., and Collen, D. (1993) Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis J Clin Invest 92, 2756–60.

    Article  PubMed  CAS  Google Scholar 

  201. Bugge, T.H., Xiao, Q., Kombrinck, K.W., Flick, M.J., Holmback, K., Danton, M.J., Colbert, M.C., Witte, D.P., Fujikawa, K., Davie, E.W., and Degen, J.L. (1996) Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation Proc Natl Acad Sci USA 93, 6258–63.

    Article  PubMed  CAS  Google Scholar 

  202. Carmeliet, P., Mackman, N., Moons, L., Luther, T., Gressens, P., Van Vlaenderen, I., Demunck, H., Kasper, M., Breier, G., Evrard, P., Muller, M., Risau, W., Edgington, T., and Collen, D. (1996) Role of tissue factor in embryonic blood vessel development Nature 383, 73–5.

    Article  PubMed  CAS  Google Scholar 

  203. Toomey, J.R., Kratzer, K.E., Lasky, N.M., Stanton, J.J., and Broze, G.J., Jr. (1996) Targeted disruption of the murine tissue factor gene results in embryonic lethality Blood 88, 1583–7.

    PubMed  CAS  Google Scholar 

  204. Huang, Z.F., Higuchi, D., Lasky, N., and Broze, G.J., Jr. (1997) Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice Blood 90, 944–51.

    PubMed  CAS  Google Scholar 

  205. Healy, A.M., Rayburn, H.B., Rosenberg, R.D., and Weiler, H. (1995) Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system Proc Natl Acad Sci USA 92, 850–4.

    Article  PubMed  CAS  Google Scholar 

  206. Connolly, A.J., Ishihara, H., Kahn, M.L., Farese, R.V., Jr., and Coughlin, S.R. (1996) Role of the thrombin receptor in development and evidence for a second receptor Nature 381, 516–9.

    Article  PubMed  CAS  Google Scholar 

  207. Cui, J., O’Shea, K.S., Purkayastha, A., Saunders, T.L., and Ginsburg, D. (1996) Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V Nature 384, 66–8.

    Article  PubMed  CAS  Google Scholar 

  208. Lin, H.F., Maeda, N., Smithies, O., Straight, D.L., and Stafford, D.W. (1997) A coagulation factor IX-deficient mouse model for human hemophilia B Blood 90, 3962–6.

    PubMed  CAS  Google Scholar 

  209. Kung, S.H., Hagstrom, J.N., Cass, D., Tai, S.J., Lin, H.F., Stafford, D.W., and High, K.A. (1998) Human factor IX corrects the bleeding diathesis of mice with hemophilia B Blood 91, 784–90.

    PubMed  CAS  Google Scholar 

  210. Evans, J.P., Brinkhous, K.M., Brayer, G.D., Reisner, H.M., and High, K.A. (1989) Canine hemophilia B resulting from a point mutation with unusual consequences Proc Natl Acad Sci USA 86, 10095–9.

    Article  PubMed  CAS  Google Scholar 

  211. Herzog, R.W., Yang, E.Y., Couto, L.B., Hagstrom, J.N., Elwell, D., Fields, P.A., Burton, M., Bellinger, D.A., Read, M.S., Brinkhous, K.M., Podsakoff, G.M., Nichols, T.C., Kurtzman, G.J., and High, K.A. (1999) Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector Nat Med 5, 56–63.

    Article  PubMed  CAS  Google Scholar 

  212. Kawasaki T., Dewerchin M., Lijnen H.R., Vermylen J., Hoylaerts M.F. (2000) Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysis during acute arterial thrombosis in mice. Blood 96, 153–60.

    Article  PubMed  CAS  Google Scholar 

  213. Waugh, J.M., Yuksel, E., Li, J., Kuo, M.D., Kattash, M., Saxena, R., Geske, R., Thung, S.N., Shenaq, S.M., and Woo, S.L. (1999) Local overexpression of thrombomodulin for in vivo prevention of arterial thrombosis in a rabbit model Circ Res 84, 84–92.

    Article  PubMed  CAS  Google Scholar 

  214. Waugh, J.M., Kattash, M., Li, J., Yuksel, E., Kuo, M.D., Lussier, M., Weinfeld, A.B., Saxena, R., Rabinovsky, E.D., Thung, S., Woo, S.L., and Shenaq, S.M. (1999) Gene therapy to promote thromboresistance: local overexpression of tissue plasminogen activator to prevent arterial thrombosis in an in vivo rabbit model Proc Natl Acad Sci USA 96, 1065–70.

    Article  PubMed  CAS  Google Scholar 

  215. Zoldhelyi, P., McNatt, J., Shelat, H.S., Yamamoto, Y., Chen, Z.Q., and Willerson, J.T. (2000) Thromboresistance of balloon-injured porcine carotid arteries after local gene transfer of human tissue factor pathway inhibitor Circulation 101, 289–95.

    Article  PubMed  CAS  Google Scholar 

  216. Vassalli, G., and Dichek, D.A. (1997) Gene therapy for arterial thrombosis Cardiovasc Res 35, 459–69.

    Article  PubMed  CAS  Google Scholar 

  217. Suh, T.T., Holmback, K., Jensen, N.J., Daugherty, C.C., Small, K., Simon, D.I., Potter, S., and Degen, J.L. (1995) Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice Genes Develop 9, 2020–33.

    Article  PubMed  CAS  Google Scholar 

  218. Yang, T.L., Cui, J., Taylor, J.M., Yang, A., Gruber, S.B., and Ginsburg, D. (2000) Rescue of fatal neonatal hemorrhage in factor V deficient mice by low level transgene expression Thromb Haemost 83, 70–7.

    PubMed  CAS  Google Scholar 

  219. Rosen, E.D., Chan, J.C., Idusogie, E., Clotman, F., Vlasuk, G., Luther, T., Jalbert, L.R., Albrecht, S., Zhong, L., Lissens, A., Schoonjans, L., Moons, L., Collen, D., Castellino, F.J., and Carmeliet, P. (1997) Mice lacking factor VII develop normally but suffer fatal perinatal bleeding Nature 390, 290–4.

    Article  PubMed  CAS  Google Scholar 

  220. Bi, L., Lawler, A.M., Antonarakis, S.E., High, K.A., Gearhart, J.D., and Kazazian, H.H., Jr. (1995) Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A Nat Genet 10, 119–21.

    Article  PubMed  CAS  Google Scholar 

  221. Kundu, R.K., Sangiorgi, F., Wu, L.Y., Kurachi, K., Anderson, W.F., Maxson, R., and Gordon, E.M. (1998) Targeted inactivation of the coagulation factor IX gene causes hemophilia B in mice Blood 92, 168–74.

    PubMed  CAS  Google Scholar 

  222. Dewerchin, M., Liang, Z., Moons, L., Carmeliet, P., Castellino, F.J., Collen, D., and Rosen, E.D. (2000) Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice Thromb Haemost 83, 185–90.

    PubMed  CAS  Google Scholar 

  223. Gailani, D., Lasky, N.M., and Broze, G.J., Jr. (1997) A murine model of factor XI deficiency Blood Coagul Fibrinolysis 8, 134–44.

    Article  PubMed  CAS  Google Scholar 

  224. Toomey, J.R., Kratzer, K.E., Lasky, N.M., and Broze, G.J., Jr. (1997) Effect of tissue factor deficiency on mouse and tumor development Proc Natl Acad Sci USA 94, 6922–6.

    Article  PubMed  CAS  Google Scholar 

  225. Darrow, A.L., Fung-Leung, W.P., Ye, R.D., Santulli, R.J., Cheung, W.M., Derian, C.K., Burns, C.L., Damiano, B.P., Zhou, L., Keenan, C.M., Peterson, P.A., and Andrade-Gordon, P. (1996) Biological consequences of thrombin receptor deficiency in mice Thromb Haemost 76, 860–6.

    PubMed  CAS  Google Scholar 

  226. Healy, A.M., Hancock, W.W., Christie, P.D., Rayburn, H.B., and Rosenberg, R.D. (1998) Intravascular coagulation activation in a murine model of thrombomodulin deficiency: effects of lesion size, age, and hypoxia on fibrin deposition Blood 92, 4188–97.

    PubMed  CAS  Google Scholar 

  227. Weiler-Guettler, H., Christie, P.D., Beeler, D.L., Healy, A.M., Hancock, W.W., Rayburn, H., Edelberg, J.M., and Rosenberg, R.D. (1998) A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state J Clin Invest 101, 1983–91.

    Article  PubMed  CAS  Google Scholar 

  228. Jalbert, L.R., Rosen, E.D., Moons, L., Chan, J.C., Carmeliet, P., Collen, D., and Castellino, F.J. (1998) Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice J Clin Invest 102, 1481–8.

    Article  PubMed  CAS  Google Scholar 

  229. Lijnen, H.R., Okada, K., Matsuo, O., Collen, D., and Dewerchin, M. (1999) Alpha2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding Blood 93, 2274–81.

    PubMed  CAS  Google Scholar 

  230. Eitzman, D.T., McCoy, R.D., Zheng, X., Fay, W.P., Shen, T., Ginsburg, D., and Simon, R.H. (1996) Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene J Clin Invest 97, 232–7.

    Article  PubMed  CAS  Google Scholar 

  231. Erickson, L.A., Fici, G.J., Lund, J.E., Boyle, T.P., Polites, H.G., and Marotti, K.R. (1990) Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene Nature 346, 74–6.

    Article  PubMed  CAS  Google Scholar 

  232. Pinsky, D.J., Liao, H., Lawson, C.A., Yan, S.F., Chen, J., Carmeliet, P., Loskutoff, D.J., and Stern, D.M. (1998) Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition J Clin Invest 102, 919–28.

    Article  PubMed  CAS  Google Scholar 

  233. Eitzman, D.T., Westrick, R.J., Nabel, E.G., and Ginsburg, D. (2000) Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice Blood 95, 577–80.

    PubMed  CAS  Google Scholar 

  234. Zheng, X., Saunders, T.L., Camper, S.A., Samuelson, L.C., and Ginsburg, D. (1995) Vitronectin is not essential for normal mammalian development and fertility Proc Natl Acad Sci USA 92, 12426–30.

    Article  PubMed  CAS  Google Scholar 

  235. Heckel, J.L., Sandgren, E.P., Degen, J.L., Palmiter, R.D., and Brinster, R.L. (1990) Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator Cell 62, 447–56.

    Article  PubMed  CAS  Google Scholar 

  236. Bugge, T.H., Flick, M.J., Danton, M.J., Daugherty, C.C., Romer, J., Dano, K., Carmeliet, P., Collen, D., and Degen, J.L. (1996) Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator Proc Natl Acad Sci USA 93, 5899–904.

    Article  PubMed  CAS  Google Scholar 

  237. Bugge, T.H., Suh, T.T., Flick, M.J., Daugherty, C.C., Romer, J., Solberg, H., Ellis, V., Dano, K., and Degen, J.L. (1995) The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility J Biol Chem 270, 16886–94.

    Article  PubMed  CAS  Google Scholar 

  238. Dewerchin, M., Nuffelen, A.V., Wallays, G., Bouche, A., Moons, L., Carmeliet, P., Mulligan, R.C., and Collen, D. (1996) Generation and characterization of urokinase receptor-deficient mice J Clin Invest 97, 870–8.

    Article  PubMed  CAS  Google Scholar 

  239. Piguet, P.F., Da Laperrousaz, C., Vesin, C., Tacchini-Cottier, F., Senaldi, G., and Grau, G.E. (2000) Delayed mortality and attenuated thrombocytopenia associated with severe malaria in urokinase- and urokinase receptor-deficient mice Infect Immun 68, 3822–9.

    Article  PubMed  CAS  Google Scholar 

  240. Ware, J., Russell, S., and Ruggeri, Z.M. (2000) Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome Proc Natl Acad Sci USA 97, 2803–8.

    Article  PubMed  CAS  Google Scholar 

  241. Ramakrishnan, V., Reeves, P.S., DeGuzman, F., Deshpande, U., Ministri-Madrid, K., DuBridge, R.B., and Phillips, D.R. (1999) Increased thrombin responsiveness in platelets from mice lacking glycoprotein V Proc Natl Acad Sci USA 96, 13336–41.

    Article  PubMed  CAS  Google Scholar 

  242. Tronik-Le Roux, D., Roullot, V., Poujol, C., Kortulewski, T., Nurden, P., and Marguerie, G. (2000) Thrombasthenic mice generated by replacement of the integrin alpha(IIb) gene: demonstration that transcriptional activation of this megakaryocytic locus precedes lineage commitment Blood 96, 1399–408.

    Google Scholar 

  243. McHugh, K.P., Hodivala-Dilke, K., Zheng, M.H., Namba, N., Lam, J., Novack, D., Feng, X., Ross, F.P., Hynes, R.O., and Teitelbaum, S.L. (2000) Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts J Clin Invest 105, 433–40.

    Article  PubMed  CAS  Google Scholar 

  244. Nieswandt, B., Brakebusch, C., Bergmeier, W., Schulte, V., Bouvard, D., Mokhtari-Nejad, R., Lindhout, T., Heemskerk, J.W., Zirngibl, H., and Fassler, R. (2001) Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen EMBO J 20, 2120–30.

    Article  PubMed  CAS  Google Scholar 

  245. Ni, H., Denis, C.V., Subbarao, S., Degen, J.L., Sato, T.N., Hynes, R.O., and Wagner, D.D. (2000) Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen J Clin Invest 106, 385–92.

    Article  PubMed  CAS  Google Scholar 

  246. Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., Ueno, A., Oh-ishi, S., and Narumiya, S. (1997) Altered pain perception and inflammatory response in mice lacking prostacyclin receptor Nature 388, 678–82.

    Article  PubMed  CAS  Google Scholar 

  247. Duncan, G.S., Andrew, D.P., Takimoto, H., Kaufman, S.A., Yoshida, H., Spellberg, J., Luis de la Pompa, J., Elia, A., Wakeham, A., Karan-Tamir, B., Muller, W.A., Senaldi, G., Zukowski, M.M., and Mak, T.W. (1999) Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions J Immunol 162, 3022–30.

    PubMed  CAS  Google Scholar 

  248. Mahooti, S., Graesser, D., Patil, S., Newman, P., Duncan, G., Mak, T., and Madri, J.A. (2000) PECAM-1 (CD31) expression modulates bleeding time in vivo Am J Pathol 157, 75–81.

    Article  PubMed  CAS  Google Scholar 

  249. Huang, L., Kuo, Y.M., and Gitschier, J. (1999) The pallid gene encodes a novel, syntaxin 13-interacting protein involved in platelet storage pool deficiency Nat Genet 23, 329–32.

    Article  PubMed  CAS  Google Scholar 

  250. Ohlmann, P., Eckly, A., Freund, M., Cazenave, J.P., Offermanns, S., and Gachet, C. (2000) ADP induces partial platelet aggregation without shape change and potentiates collagen-induced aggregation in the absence of Galphaq Blood 96, 2134–9.

    PubMed  CAS  Google Scholar 

  251. Wang, D., Feng, J., Wen, R., Marine, J.C., Sangster, M.Y., Parganas, E., Hoffmeyer, A., Jackson, C.W., Cleveland, J.L., Murray, P.J., and Ihle, J.N. (2000) Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors Immunity 13, 25–35.

    Article  PubMed  Google Scholar 

  252. Enjyoji, K., Sevigny, J., Lin, Y., Frenette, P.S., Christie, P.D., Esch, J.S., 2nd, Imai, M., Edelberg, J.M., Rayburn, H., Lech, M., Beeler, D.L., Csizmadia, E., Wagner, D.D., Robson, S.C., and Rosenberg, R.D. (1999) Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation Nat Med 5, 1010–7.

    Article  PubMed  CAS  Google Scholar 

  253. Massberg, S., Sausbier, M., Klatt, P., Bauer, M., Pfeifer, A., Siess, W., Fassler, R., Ruth, P., Krombach, F., and Hofmann, F. (1999) Increased adhesion and aggregation of platelets lacking cyclic guanosine 3ʹ,5ʹ-monophosphate kinase I J Exp Med 189, 1255–64.

    Article  PubMed  CAS  Google Scholar 

  254. Aszodi, A., Pfeifer, A., Ahmad, M., Glauner, M., Zhou, X.H., Ny, L., Andersson, K.E., Kehrel, B., Offermanns, S., and Fassler, R. (1999) The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function EMBO J 18, 37–48.

    Article  PubMed  CAS  Google Scholar 

  255. Hauser, W., Knobeloch, K.P., Eigenthaler, M., Gambaryan, S., Krenn, V., Geiger, J., Glazova, M., Rohde, E., Horak, I., Walter, U., and Zimmer, M. (1999) Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice Proc Natl Acad Sci USA 96, 8120–5.

    Article  PubMed  CAS  Google Scholar 

  256. Chen, X.S., Sheller, J.R., Johnson, E.N., and Funk, C.D. (1994) Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene Nature 372, 179–82.

    Article  PubMed  CAS  Google Scholar 

  257. Johnson, E.N., Brass, L.F., and Funk, C.D. (1998) Increased platelet sensitivity to ADP in mice lacking platelet-type 12-lipoxygenase Proc Nat Acad Sci USA 95, 3100–5.

    Article  PubMed  CAS  Google Scholar 

  258. Lawler, J., Sunday, M., Thibert, V., Duquette, M., George, E.L., Rayburn, H., and Hynes, R.O. (1998) Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia J Clin Invest 101, 982–92.

    Article  PubMed  CAS  Google Scholar 

  259. Schumacher, W.A., Steinbacher, T.E., Megill, J.R., and Durham, S.K. (1996) A ferret model of electrical-induction of arterial thrombosis that is sensitive to aspirin J Pharmacol Toxicol Methods 35, 3–10.

    Article  PubMed  CAS  Google Scholar 

  260. Sloan, M.A., and Gore, J.M. (1992) Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: a risk-benefit analysis Am J Cardiol 69, 21A–38A.

    Article  PubMed  CAS  Google Scholar 

  261. Stieg, P.E., and Kase, C.S. (1998) Intracranial hemorrhage: diagnosis and emergency management Neurolog Clin 16, 373–90.

    Article  CAS  Google Scholar 

  262. Bernardi, M.M., Califf, R.M., Kleiman, N., Ellis, S.G., and Topol, E.J. (1993) Lack of usefulness of prolonged bleeding times in predicting hemorrhagic events in patients receiving the 7E3 glycoprotein IIb/IIIa platelet antibody. The TAMI Study Group Am J Cardiol 72, 1121–5.

    Article  PubMed  CAS  Google Scholar 

  263. Bick, R.L. (1995) Laboratory evaluation of platelet dysfunction Clin Lab Med 15, 1–38.

    PubMed  CAS  Google Scholar 

  264. Rodgers, R.P., and Levin, J. (1990) A critical reappraisal of the bleeding time Semin Thromb Hemost 16, 1–20.

    Article  PubMed  CAS  Google Scholar 

  265. (1996) A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. The global use of strategies to open occluded coronary arteries (GUSTO) IIb investigators N Engl J Med 335, 775–82.

    Google Scholar 

  266. Antman, E.M. (1996) Hirudin in acute myocardial infarction. Thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9B trial Circulation 94, 911–21.

    Article  PubMed  CAS  Google Scholar 

  267. Cox, D., Motoyama, Y., Seki, J., Aoki, T., Dohi, M., and Yoshida, K. (1992) Pentamidine: a non-peptide GPIIb/IIIa antagonist–in vitro studies on platelets from humans and other species Thromb Haemost 68, 731–6.

    PubMed  CAS  Google Scholar 

  268. Bostwick, J.S., Kasiewski, C.J., Chu, V., Klein, S.I., Sabatino, R.D., Perrone, M.H., Dunwiddie, C.T., Cook, J.J., and Leadley, R.J., Jr. (1996) Anti-thrombotic activity of RG13965, a novel platelet fibrinogen receptor antagonist Thromb Res 82, 495–507.

    Article  PubMed  CAS  Google Scholar 

  269. Cook, N.S., Zerwes, H.G., Tapparelli, C., Powling, M., Singh, J., Metternich, R., and Hagenbach, A. (1993) Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists Thromb Haemost 70, 531–9.

    PubMed  CAS  Google Scholar 

  270. Panzer-Knodle, S., Taite, B.B., Mehrotra, D.V., Nicholson, N.S., and Feigen, L.P. (1993) Species variation in the effect of glycoprotein IIb/IIIa antagonists on inhibition of platelet aggregation J Pharmacol Toxicol Methods 30, 47–53.

    Article  PubMed  CAS  Google Scholar 

  271. Cook, J.J., Holahan, M.A., Lyle, E.A., Ramjit, D.R., Sitko, G.R., Stranieri, M.T., Stupienski, R.F., 3rd, Wallace, A.A., Hand, E.L., Gehret, J.R., Kothstein, T., Drag, M.D., McCormick, G.Y., Perkins, J.J., Ihle, N.C., Duggan, M.E., Hartman, G.D., Gould, R.J., and Lynch, J.J., Jr. (1996) Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217 J Pharmacol Exp Therap 278, 62–73.

    CAS  Google Scholar 

  272. Nutt, E.M., Jain, D., Lenny, A.B., Schaffer, L., Siegl, P.K., and Dunwiddie, C.T. (1991) Purification and characterization of recombinant antistasin: a leech-derived inhibitor of coagulation factor Xa Arch Biochem Biophys 285, 37–44.

    Article  PubMed  CAS  Google Scholar 

  273. Taniuchi, Y., Sakai, Y., Hisamichi, N., Kayama, M., Mano, Y., Sato, K., Hirayama, F., Koshio, H., Matsumoto, Y., and Kawasaki, T. (1998) Biochemical and pharmacological characterization of YM-60828, a newly synthesized and orally active inhibitor of human factor Xa Thromb Haemost 79, 543–8.

    PubMed  CAS  Google Scholar 

  274. Tidwell, R.R., Webster, W.P., Shaver, S.R., and Geratz, J.D. (1980) Strategies for anticoagulation with synthetic protease inhibitors. Xa inhibitors versus thrombin inhibitors Thromb Res 19, 339–49.

    Article  PubMed  CAS  Google Scholar 

  275. Kararli, T.T. (1995) Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals Biopharmaceut Drug Dispos 16, 351–80.

    Article  CAS  Google Scholar 

  276. Sanderson, P.E., Cutrona, K.J., Dorsey, B.D., Dyer, D.L., McDonough, C.M., Naylor-Olsen, A.M., Chen, I.W., Chen, Z., Cook, J.J., Gardell, S.J., Krueger, J.A., Lewis, S.D., Lin, J.H., Lucas, B.J., Jr., Lyle, E.A., Lynch, J.J., Jr., Stranieri, M.T., Vastag, K., Shafer, J.A., and Vacca, J.P. (1998) L-374,087, an efficacious, orally bioavailable, pyridinone acetamide thrombin inhibitor Bioorg Med Chem Lett 8, 817–22.

    Article  PubMed  CAS  Google Scholar 

  277. Sun, W.Y., Witte, D.P., Degen, J.L., Colbert, M.C., Burkart, M.C., Holmback, K., Xiao, Q., Bugge, T.H., and Degen, S.J. (1998) Prothrombin deficiency results in embryonic and neonatal lethality in mice Proc Natl Acad Sci USA 95, 7597–602.

    Article  PubMed  CAS  Google Scholar 

  278. Xue, J., Wu, Q., Westfield, L.A., Tuley, E.A., Lu, D., Zhang, Q., Shim, K., Zheng, X., and Sadler, J.E. (1998) Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice Proc Natl Acad Sci USA 95, 7603–7.

    Article  PubMed  CAS  Google Scholar 

  279. Matsuo, O., Rijken, D.C., and Collen, D. (1981) Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus Nature 291, 590–1.

    Article  PubMed  CAS  Google Scholar 

  280. Collen, D., Topol, E.J., Tiefenbrunn, A.J., Gold, H.K., Weisfeldt, M.L., Sobel, B.E., Leinbach, R.C., Brinker, J.A., Ludbrook, P.A., and Yasuda, I., et al. (1984) Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial Circulation 70, 1012–7.

    Article  PubMed  CAS  Google Scholar 

  281. Topol, E.J., Califf, R.M., Weisman, H.F., Ellis, S.G., Tcheng, J.E., Worley, S., Ivanhoe, R., George, B.S., Fintel, D., and Weston, M., et al. (1994) Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC investigators Lancet 343, 881–6.

    Article  PubMed  CAS  Google Scholar 

  282. Lynch, J.J., Jr., Sitko, G.R., Lehman, E.D., and Vlasuk, G.P. (1995) Primary prevention of coronary arterial thrombosis with the factor Xa inhibitor rTAP in a canine electrolytic injury model Thromb Haemost 74, 640–5.

    PubMed  CAS  Google Scholar 

  283. (1998) Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet receptor inhibition in ischemic syndrome management in patients limited by unstable signs and symptoms (PRISM-PLUS) study investigators N Engl J Med 338, 1488–97.

    Google Scholar 

  284. Ohman, E.M., Kleiman, N.S., Gacioch, G., Worley, S.J., Navetta, F.I., Talley, J.D., Anderson, H.V., Ellis, S.G., Cohen, M.D., Spriggs, D., Miller, M., Kereiakes, D., Yakubov, S., Kitt, M.M., Sigmon, K.N., Califf, R.M., Krucoff, M.W., and Topol, E.J. (1997) Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI investigators Circulation 95, 846–54.

    Article  PubMed  CAS  Google Scholar 

  285. Cohen, M., Demers, C., Gurfinkel, E.P., Turpie, A.G., Fromell, G.J., Goodman, S., Langer, A., Califf, R.M., Fox, K.A., Premmereur, J., and Bigonzi, F. (1998) Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and safety of subcutaneous enoxaparin versus intravenous unfractionated heparin, in non-Q-wave coronary events Am J Cardiol 82, 19L–24L.

    Article  PubMed  CAS  Google Scholar 

  286. Agnelli, G., Pascucci, C., Cosmi, B., and Nenci, G.G. (1990) The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits Thromb Haemost 63, 204–7.

    PubMed  CAS  Google Scholar 

  287. Eriksson, B.I., Wille-Jorgensen, P., Kalebo, P., Mouret, P., Rosencher, N., Bosch, P., Baur, M., Ekman, S., Bach, D., Lindbratt, S., and Close, P. (1997) A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement N Engl J Med 337, 1329–35.

    Article  PubMed  CAS  Google Scholar 

  288. Fitzgerald, D.J., Wright, F., and FitzGerald, G.A. (1989) Increased thromboxane biosynthesis during coronary thrombolysis. Evidence that platelet activation and thromboxane A2 modulate the response to tissue-type plasminogen activator in vivo Circ Res 65, 83–94.

    Article  PubMed  CAS  Google Scholar 

  289. Gold, H.K., Torres, F.W., Garabedian, H.D., Werner, W., Jang, I.K., Khan, A., Hagstrom, J.N., Yasuda, T., Leinbach, R.C., and Newell, J.B., et al. (1993) Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris J Am Coll Cardiol 21, 1039–47.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA

    Shaker A. Mousa

Authors
  1. Shaker A. Mousa
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. , Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sc, Discovery Drive One, Rensselaer, 12144, New York, USA

    Shaker A. Mousa

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Mousa, S.A. (2010). In Vivo Models for the Evaluation of Antithrombotics and Thrombolytics. In: Mousa, S. (eds) Anticoagulants, Antiplatelets, and Thrombolytics. Methods in Molecular Biology, vol 663. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-803-4_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-803-4_2

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-802-7

  • Online ISBN: 978-1-60761-803-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation